Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Phase I Study of Single-Agent Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Patients with Advanced Cancer.

Segal NH, He AR, Doi T, Levy R, Bhatia S, Pishvaian MJ, Cesari R, Chen Y, Davis CB, Huang B, Thall AD, Gopal AK.

Clin Cancer Res. 2018 Apr 15;24(8):1816-1823. doi: 10.1158/1078-0432.CCR-17-1922. Epub 2018 Mar 16.

2.

Phase Ib Study of Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Combination with Pembrolizumab (MK-3475) in Patients with Advanced Solid Tumors.

Tolcher AW, Sznol M, Hu-Lieskovan S, Papadopoulos KP, Patnaik A, Rasco DW, Di Gravio D, Huang B, Gambhire D, Chen Y, Thall AD, Pathan N, Schmidt EV, Chow LQM.

Clin Cancer Res. 2017 Sep 15;23(18):5349-5357. doi: 10.1158/1078-0432.CCR-17-1243. Epub 2017 Jun 20.

3.

Characterization of anti-Gal antibody-producing cells of baboons and humans.

Xu Y, Yang YG, Ohdan H, Ryan D, Harper D, Wu C, Kruger-Grey HS, Thall AD, Awwad M, Sykes M.

Transplantation. 2006 Mar 27;81(6):940-8.

PMID:
16570021
4.

Promotion of xenogeneic hematopoietic chimerism in rodents by mononuclear phagocyte depletion.

Cheng J, Glaser RM, Kruger-Grey H, White-Scharf ME, Cooper DK, Thall AD.

Xenotransplantation. 2002 Nov;9(6):402-9.

PMID:
12371936
5.

Elimination of porcine hemopoietic cells by macrophages in mice.

Abe M, Cheng J, Qi J, Glaser RM, Thall AD, Sykes M, Yang YG.

J Immunol. 2002 Jan 15;168(2):621-8.

6.

The alpha(1,3)fucosyltransferases FucT-IV and FucT-VII exert collaborative control over selectin-dependent leukocyte recruitment and lymphocyte homing.

Homeister JW, Thall AD, Petryniak B, Malý P, Rogers CE, Smith PL, Kelly RJ, Gersten KM, Askari SW, Cheng G, Smithson G, Marks RM, Misra AK, Hindsgaul O, von Andrian UH, Lowe JB.

Immunity. 2001 Jul;15(1):115-26.

7.

In vivo T-cell depletion enhances production of anti-GALalpha1,3GAL natural antibodies in alpha1,3-galactosyltransferase-deficient mice.

Ohdan H, Yang YG, Swenson KG, Thall AD, Sykes M.

Transplantation. 2000 Mar 15;69(5):910-3.

PMID:
10755549
8.
9.

Inhibition of human anti-pig T cell response by anti-CD2, anti-CD40L, and CTLA4-Ig: a comparative study.

Xu Y, Ryan D, Wu C, Bazin H, Latinne D, White-Scharf ME, Thall AD.

Transplant Proc. 2000 Aug;32(5):926. No abstract available.

PMID:
10936275
10.

In vitro and in vivo inhibition of anti-gal secreting cells.

Xu Y, Ryan D, Wu C, Kiessling L, Xu J, Morgan P, Vitetta E, White-Scharf ME, Thall AD.

Transplant Proc. 2000 Aug;32(5):856. No abstract available.

PMID:
10936242
11.

P-selectin glycoprotein ligand-1 and E-selectin ligand-1 are differentially modified by fucosyltransferases Fuc-TIV and Fuc-TVII in mouse neutrophils.

Huang MC, Zöllner O, Moll T, Maly P, Thall AD, Lowe JB, Vestweber D.

J Biol Chem. 2000 Oct 6;275(40):31353-60.

12.

Blockade of CD28-B7, but not CD40-CD154, prevents costimulation of allogeneic porcine and xenogeneic human anti-porcine T cell responses.

Lee RS, Yamada K, Womer KL, Pillsbury EP, Allison KS, Marolewski AE, Geng D, Thall AD, Arn JS, Sachs DH, Sayegh MH, Madsen JC.

J Immunol. 2000 Mar 15;164(6):3434-44.

13.

Generation of alpha 1,3galactosyltransferase deficient mice.

Thall AD.

Subcell Biochem. 1999;32:259-79. Review. No abstract available.

PMID:
10391999
14.

Pharmacologic immunosuppressive therapy and extracorporeal immunoadsorption in the suppression of anti-alphaGal antibody in the baboon.

Lambrigts D, Van Calster P, Xu Y, Awwad M, Neethling FA, Kozlowski T, Foley A, Watts A, Chae SJ, Fishman J, Thall AD, White-Scharf ME, Sachs DH, Cooper DK.

Xenotransplantation. 1998 Nov;5(4):274-83.

PMID:
9915255
15.

A murine model of antibody-mediated hyperacute rejection by galactose-alpha(1,3)galactose antibodies in Gal o/o mice.

McKenzie IF, Li YQ, Patton K, Thall AD, Sandrin MS.

Transplantation. 1998 Sep 27;66(6):754-63.

PMID:
9771839
16.

Tolerization of anti-Galalpha1-3Gal natural antibody-forming B cells by induction of mixed chimerism.

Yang YG, deGoma E, Ohdan H, Bracy JL, Xu Y, Iacomini J, Thall AD, Sykes M.

J Exp Med. 1998 Apr 20;187(8):1335-42.

17.

Xenoantigens and xenoantibodies: their modification.

Cooper DK, Thall AD.

World J Surg. 1997 Nov-Dec;21(9):901-6. Review.

PMID:
9361502
18.

alpha 1,3-Galactosyltransferase-deficient mice produce naturally occurring cytotoxic anti-Gal antibodies.

Thall AD, Murphy HS, Lowe JB.

Transplant Proc. 1996 Apr;28(2):556-7. No abstract available.

PMID:
8623267

Supplemental Content

Loading ...
Support Center